###begin article-title 0
###xml 20 27 20 27 <italic>de novo</italic>
###xml 118 121 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Np95 interacts with de novo DNA methyltransferases, Dnmt3a and Dnmt3b, and mediates epigenetic silencing of the viral CMV promoter in embryonic stem cells
###end article-title 0
###begin p 1
These authors contributed equally to this work
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation without specific permission.
###end p 2
###begin p 3
###xml 267 274 267 274 <italic>de novo</italic>
Recent studies have indicated that nuclear protein of 95 kDa (Np95) is essential for maintaining genomic methylation by recruiting DNA methyltransferase (Dnmt) 1 to hemi-methylated sites. Here, we show that Np95 interacts more strongly with regulatory domains of the de novo methyltransferases Dnmt3a and Dnmt3b. To investigate possible functions, we developed an epigenetic silencing assay using fluorescent reporters in embryonic stem cells (ESCs). Interestingly, silencing of the cytomegalovirus promoter in ESCs preceded DNA methylation and was strictly dependent on the presence of either Np95, histone H3 methyltransferase G9a or Dnmt3a and Dnmt3b. Our results indicate a regulatory role for Np95, Dnmt3a and Dnmt3b in mediating epigenetic silencing through histone modification followed by DNA methylation.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 187 197 187 197 <xref ref-type="bibr" rid="b4">Bird, 2002</xref>
###xml 464 471 464 471 <italic>de novo</italic>
###xml 553 558 553 558 <italic>et al</italic>
###xml 543 564 543 564 <xref ref-type="bibr" rid="b16">Leonhardt <italic>et al</italic>, 1992</xref>
###xml 569 574 569 574 <italic>et al</italic>
###xml 566 580 566 580 <xref ref-type="bibr" rid="b17">Li <italic>et al</italic>, 1992</xref>
###xml 586 591 586 591 <italic>et al</italic>
###xml 582 597 582 597 <xref ref-type="bibr" rid="b15">Lei <italic>et al</italic>, 1996</xref>
###xml 605 610 605 610 <italic>et al</italic>
###xml 599 616 599 616 <xref ref-type="bibr" rid="b20">Okano <italic>et al</italic>, 1999</xref>
###xml 624 629 624 629 <italic>et al</italic>
###xml 618 635 618 635 <xref ref-type="bibr" rid="b25">Spada <italic>et al</italic>, 2007</xref>
###xml 792 797 792 797 <italic>et al</italic>
###xml 784 803 784 803 <xref ref-type="bibr" rid="b5">Bostick <italic>et al</italic>, 2007</xref>
###xml 812 817 812 817 <italic>et al</italic>
###xml 805 823 805 823 <xref ref-type="bibr" rid="b24">Sharif <italic>et al</italic>, 2007</xref>
###xml 832 837 832 837 <italic>et al</italic>
###xml 825 843 825 843 <xref ref-type="bibr" rid="b1">Achour <italic>et al</italic>, 2008</xref>
###xml 846 851 846 851 <italic>dnmt1</italic>
###xml 851 854 851 854 <sup>&#8722;/&#8722;</sup>
###xml 859 863 859 863 <italic>np95</italic>
###xml 863 866 863 866 <sup>&#8722;/&#8722;</sup>
###xml 1140 1145 1140 1145 <italic>et al</italic>
###xml 1133 1151 1133 1151 <xref ref-type="bibr" rid="b26">Uemura <italic>et al</italic>, 2000</xref>
###xml 1161 1166 1161 1166 <italic>et al</italic>
###xml 1153 1172 1153 1172 <xref ref-type="bibr" rid="b5">Bostick <italic>et al</italic>, 2007</xref>
###xml 1181 1186 1181 1186 <italic>et al</italic>
###xml 1174 1192 1174 1192 <xref ref-type="bibr" rid="b21">Papait <italic>et al</italic>, 2007</xref>
###xml 1200 1205 1200 1205 <italic>et al</italic>
###xml 1194 1211 1194 1211 <xref ref-type="bibr" rid="b2">Arita <italic>et al</italic>, 2008</xref>
###xml 1223 1228 1223 1228 <italic>et al</italic>
###xml 1213 1234 1213 1234 <xref ref-type="bibr" rid="b3">Avvakumov <italic>et al</italic>, 2008</xref>
###xml 1246 1251 1246 1251 <italic>et al</italic>
###xml 1236 1257 1236 1257 <xref ref-type="bibr" rid="b12">Hashimoto <italic>et al</italic>, 2008</xref>
In mammals, DNA methylation contributes to the establishment and maintenance of cell-type-specific gene expression programmes, imprinting, X-chromosome inactivation and genome stability (Bird, 2002). The majority of genomic methylation occurs at cytosine residues within CpG dinucleotides and is catalysed by the DNA methyltransferases (Dnmt) 1, 3a and 3b. Dnmt1 is responsible for maintaining genomic methylation, whereas Dnmt3a and Dnmt3b are mainly involved in de novo establishment of methylation patterns during cellular differentiation (Leonhardt et al, 1992; Li et al, 1992; Lei et al, 1996; Okano et al, 1999; Spada et al, 2007). Nuclear protein of 95 kDa (Np95; also known as Uhrf1) has recently been identified as an essential co-factor for maintaining genomic methylation (Bostick et al, 2007; Sharif et al, 2007; Achour et al, 2008). dnmt1-/- and np95-/- embryonic stem cells (ESCs) and embryos have similar reduced levels of DNA methylation. In addition, Np95 interacts with Dnmt1, binds hemi-methylated CpG sites through its Set and Ring associated (SRA) domain and both Np95 and Dnmt1 accumulate at replication sites (Uemura et al, 2000; Bostick et al, 2007; Papait et al, 2007; Arita et al, 2008; Avvakumov et al, 2008; Hashimoto et al, 2008). Thus, it has been proposed that Np95 mediates maintenance of genomic methylation by recruiting Dnmt1 to hemi-methylated CpG sites generated during replication.
###end p 5
###begin p 6
###xml 182 189 182 189 <italic>de novo</italic>
Here, we investigated a possible involvement of Np95 in epigenetic regulation beyond its role in Dnmt1-mediated maintenance of DNA methylation. We found that Np95 interacts with the de novo methyltransferases, Dnmt3a and Dnmt3b, and mediates promoter silencing before DNA methylation is detected.
###end p 6
###begin title 7
Results And Discussion
###end title 7
###begin title 8
Np95 interacts with Dnmt3a and Dnmt3b
###end title 8
###begin p 9
###xml 71 78 71 78 <italic>de novo</italic>
###xml 208 214 208 214 <xref ref-type="fig" rid="f1">Fig 1A</xref>
###xml 286 291 286 291 <italic>et al</italic>
###xml 276 297 276 297 <xref ref-type="bibr" rid="b22">Rothbauer <italic>et al</italic>, 2008</xref>
###xml 434 438 434 438 <italic>np95</italic>
###xml 438 441 438 441 <sup>&#8722;/&#8722;</sup>
###xml 544 550 544 550 <italic>dnmt3a</italic>
###xml 555 557 555 557 <italic>3b</italic>
###xml 586 609 586 609 <xref ref-type="supplementary-material" rid="S1">supplementary Fig S1A,B</xref>
###xml 823 844 823 844 <xref ref-type="supplementary-material" rid="S1">supplementary Fig S1C</xref>
###xml 979 984 979 984 <italic>et al</italic>
###xml 970 990 970 990 <xref ref-type="bibr" rid="b27">Zolghadr <italic>et al</italic>, 2008</xref>
###xml 1062 1065 1062 1065 <italic>lac</italic>
###xml 1212 1218 1212 1218 <xref ref-type="fig" rid="f1">Fig 1B</xref>
###xml 1625 1645 1625 1645 <xref ref-type="supplementary-material" rid="S1">supplementary Fig S2</xref>
###xml 2362 2367 2362 2367 <italic>dnmt1</italic>
###xml 2367 2370 2367 2370 <sup>&#8722;/&#8722;</sup>
###xml 2454 2475 2454 2475 <xref ref-type="supplementary-material" rid="S1">supplementary Fig S1D</xref>
###xml 2581 2587 2581 2587 <xref ref-type="fig" rid="f1">Fig 1A</xref>
###xml 2752 2773 2752 2773 <xref ref-type="supplementary-material" rid="S1">supplementary Fig S3A</xref>
###xml 3040 3046 3040 3046 <xref ref-type="fig" rid="f1">Fig 1C</xref>
###xml 3048 3069 3048 3069 <xref ref-type="supplementary-material" rid="S1">supplementary Fig S3B</xref>
###xml 3343 3350 3343 3350 <italic>de novo</italic>
###xml 741 746 <span type="species:ncbi:9606">human</span>
###xml 770 775 <span type="species:ncbi:9606">human</span>
Immunoprecipitation experiments showed that different isoforms of both de novo methyltransferases Dnmt3a and Dnmt3b interact with Np95 in wild-type (wt) ESCs, including the more abundant Dnmt3a2 and Dnmt3b1 (Fig 1A). Furthermore, using a green fluorescent protein (GFP) trap (Rothbauer et al, 2008), we co-immunoprecipitated endogenous Dnmt1 and isoforms of Dnmt3a and Dnmt3b with a GFP-Np95 fusion construct transiently expressed in np95-/- ESCs and, vice versa, endogenous Np95 co-immunoprecipitated with GFP-Dnmt3a or GFP-Dnmt3b1 fusions in dnmt3a and 3b double knockout (DKO) ESCs (supplementary Fig S1A,B online). In addition, we observed co-immunoprecipitation of endogenous DNMT3b and inverted CCAAT box binding protein of 90 kDa-the human homologue of Np95-from human embryonic kidney 293T (HEK293T) cell extracts (supplementary Fig S1C online). We confirmed the interaction of Np95 with Dnmt3a/b by using a recently developed fluorescent two hybrid assay (F2H; Zolghadr et al, 2008). GFP-Dnmt3 fusion constructs were used as bait by tethering them to a lac operator array present in baby hamster kidney (BHK) cells, so that the array was visible as a distinct nuclear spot of enriched GFP fluorescence (Fig 1B). A Cherry-Np95 fusion (prey) accumulated at this spot only when GFP fusions of full-length Dnmt3a and Dnmt3b1 or their amino-terminal regions were used as bait and not when their isolated Carboxy-terminal catalytic domains were used. We further mapped the interaction of Np95 with Dnmt3a/b through co-immunoprecipitation of deletion constructs and isolated domains transiently expressed in HEK293T cells (supplementary Fig S2 online). The results were consistent with those produced by F2H: the N-terminal regions of Dnmt3a and Dnmt3b1, but not their C-terminal catalytic domains, interacted with Np95. Deletion of the PHD or PWWP domains of Dnmt3a and Dnmt3b did not eliminate the interaction with Np95. We then determined the domains of Np95 involved in this interaction. We found that the SRA domain and the N-terminal 298 amino acids of Np95, which include the ubiquitin-like domain, interacted with Dnmt3a and Dnmt3b1, whereas the PHD domain and the C-terminal 132 amino acids, including the Ring domain, did not. Furthermore, we observed co-immunoprecipitation of endogenous Np95 with GFP-Dnmt3a and GFP-Dnmt3b transiently expressed in dnmt1-/- ESCs, indicating that Dnmt3a and Dnmt3b interact with Np95 independently of Dnmt1 (supplementary Fig S1D online). To compare the relative association between endogenous Np95 and Dnmts, we re-probed the blot in Fig 1A with a Dnmt1 antibody and observed a substantially weaker signal for the co-immunoprecipitated Dnmt1 relative to the input than in the case of Dnmt3a2 and Dnmt3b1 (supplementary Fig S3A online). To compare further the stability of Np95 interactions with the Dnmts, we transiently co-expressed Np95-His with GFP-Dnmt1, GFP-Dnmt3a or GFP-Dnmt3b1 in HEK293T cells and immunoprecipitated with the GFP trap in the presence of different salt concentrations (Fig 1C; supplementary Fig S3B online). Interestingly, under high salt conditions, the interaction between Np95-His and GFP-Dnmt1 was lost, whereas co-immunoprecipitation of GFP-Dnmt3a and GFP-Dnmt3b1 remained relatively unaffected. These data clearly indicate that Np95 interacts more strongly with the de novo methyltransferases, Dnmt3a and Dnmt3b, than with Dnmt1.
###end p 9
###begin title 10
Np95, Dnmt3a/3b and G9a mediate epigenetic silencing
###end title 10
###begin p 11
###xml 425 430 422 427 <xref ref-type="fig" rid="f2">Fig 2</xref>
###xml 962 983 959 980 <xref ref-type="supplementary-material" rid="S1">supplementary Fig S4A</xref>
###xml 1120 1125 1117 1122 <xref ref-type="fig" rid="f2">Fig 2</xref>
###xml 1207 1212 1204 1209 <italic>dnmt1</italic>
###xml 1214 1216 1211 1213 <italic>3a</italic>
###xml 1221 1223 1218 1220 <italic>3b</italic>
###xml 1309 1313 1306 1310 <italic>np95</italic>
###xml 1313 1316 1310 1313 <sup>&#8722;/&#8722;</sup>
###xml 1376 1381 1373 1378 <italic>dnmt1</italic>
###xml 1381 1384 1378 1381 <sup>&#8722;/&#8722;</sup>
###xml 1641 1662 1638 1659 <xref ref-type="supplementary-material" rid="S1">supplementary Fig S4B</xref>
###xml 2038 2042 2035 2039 <italic>np95</italic>
###xml 2042 2045 2039 2042 <sup>&#8722;/&#8722;</sup>
###xml 2083 2087 2080 2084 <italic>dnmt</italic>
###xml 2136 2141 2133 2138 <xref ref-type="fig" rid="f3">Fig 3</xref>
###xml 2143 2164 2140 2161 <xref ref-type="supplementary-material" rid="S1">supplementary Fig S5A</xref>
###xml 2304 2325 2301 2322 <xref ref-type="supplementary-material" rid="S1">supplementary Fig S5B</xref>
###xml 2405 2412 2402 2409 <italic>de novo</italic>
###xml 2443 2450 2440 2447 <italic>de novo</italic>
###xml 2884 2890 2881 2887 <xref ref-type="fig" rid="f2">Fig 2B</xref>
###xml 257 260 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 371 374 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 390 397 <span type="species:ncbi:9031">chicken</span>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 739 742 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1106 1109 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1281 1284 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1354 1357 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1893 1896 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 2341 2344 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 2743 2746 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
As DNA methylation has a central role in epigenetic silencing, we investigated the requirement of DNA methyltransferases and Np95 for promoter silencing in ESCs. We found that, on transient transfection of wt ESCs, constructs driven by the cytomegalovirus (CMV) promoter were rapidly silenced, as opposed to longer-lasting expression of constructs driven by the chimeric CMV early enhancer/chicken beta actin (CAG) promoter (Fig 2), which is consistent with the popularity of the CAG promoter for stable transgene expression in ESCs and mice. We then established an epigenetic silencing assay based on this observation. ESCs were co-transfected with two distinct plasmids, one expressing monomeric red fluorescent protein (mRFP) under the CMV promoter, the other expressing GFP driven by the CAG promoter. mRFP and GFP expression was monitored after transfection for up to ten days by using automated image acquisition and quantification of fluorescent signals (supplementary Fig S4A online). The ratio between mRFP and GFP expression declined steadily in wt ESCs, reflecting preferential silencing of the CMV promoter (Fig 2). By contrast, DKO ESCs and ESCs lacking all three major DNA methyltransferases (dnmt1, 3a and 3b triple knockout) showed no preferential silencing of the CMV promoter. Surprisingly, np95-/- ESCs were also unable to silence the CMV promoter, whereas dnmt1-/- ESCs showed only partly reduced silencing under these conditions. Similar results were obtained on swapping GFP and mRFP reporter sequences, ruling out potential artefacts due to differences in their coding sequences or stability of the reporter proteins (supplementary Fig S4B online). Thus, despite expressing a full complement of DNA methyltransferases, ESCs lacking Np95 are as deficient in promoter silencing activity as ESCs lacking all three major Dnmts. We next investigated whether silencing of the CMV promoter correlates with CpG methylation. Interestingly, promoter methylation was detected only ten days after transfection and was lower in np95-/- than in wt ESCs, whereas none of the dnmt mutant ESCs showed appreciable DNA methylation (Fig 3; supplementary Fig S5A online). At the same time no obvious methylation was detected in any of the ESC lines within the CpG island of the CAG promoter construct (supplementary Fig S5B online). Thus, CMV promoter silencing depends on the presence of both Np95 and de novo Dnmts, but ensues well before de novo methylation of the promoter is detected. This prompted us to investigate the involvement of repressive histone methylation as a possible mechanism for the observed silencing. We found that in the absence of histone H3 lysine 9 methyltransferases (H3K9MTs), G9a or Suv39h1/2, silencing of the CMV promoter was completely abolished or reduced, respectively, indicating that G9a and, in part, Suv39h1/2 are also required for silencing (Fig 2B).
###end p 11
###begin p 12
###xml 177 184 177 184 <italic>de novo</italic>
###xml 347 354 347 354 <italic>de novo</italic>
###xml 602 607 602 607 <italic>et al</italic>
###xml 597 613 597 613 <xref ref-type="bibr" rid="b10">Fuks <italic>et al</italic>, 2003</xref>
###xml 624 629 624 629 <italic>et al</italic>
###xml 615 635 615 635 <xref ref-type="bibr" rid="b14">Lehnertz <italic>et al</italic>, 2003</xref>
###xml 645 650 645 650 <italic>et al</italic>
###xml 637 656 637 656 <xref ref-type="bibr" rid="b19">Martens <italic>et al</italic>, 2005</xref>
###xml 931 936 931 936 <italic>et al</italic>
###xml 926 942 926 942 <xref ref-type="bibr" rid="b7">Dong <italic>et al</italic>, 2008</xref>
###xml 1039 1046 1039 1046 <italic>de novo</italic>
###xml 1066 1070 1066 1070 <italic>oct4</italic>
###xml 1072 1077 1072 1077 <italic>nanog</italic>
###xml 1082 1088 1082 1088 <italic>dnmt3l</italic>
###xml 1157 1162 1157 1162 <italic>et al</italic>
###xml 1149 1168 1149 1168 <xref ref-type="bibr" rid="b9">Feldman <italic>et al</italic>, 2006</xref>
###xml 1173 1178 1173 1178 <italic>et al</italic>
###xml 1170 1184 1170 1184 <xref ref-type="bibr" rid="b18">Li <italic>et al</italic>, 2007</xref>
###xml 1202 1207 1202 1207 <italic>et al</italic>
###xml 1186 1213 1186 1213 <xref ref-type="bibr" rid="b8">Epsztejn-Litman <italic>et al</italic>, 2008</xref>
###xml 1274 1281 1274 1281 <italic>de novo</italic>
###xml 1316 1320 1316 1320 <italic>oct4</italic>
###xml 1390 1395 1390 1395 <italic>nanog</italic>
###xml 1400 1406 1400 1406 <italic>dnmt3l</italic>
###xml 1426 1431 1426 1431 <italic>et al</italic>
###xml 1418 1437 1418 1437 <xref ref-type="bibr" rid="b9">Feldman <italic>et al</italic>, 2006</xref>
###xml 1455 1460 1455 1460 <italic>et al</italic>
###xml 1439 1466 1439 1466 <xref ref-type="bibr" rid="b8">Epsztejn-Litman <italic>et al</italic>, 2008</xref>
###xml 1489 1494 1489 1494 <italic>nanog</italic>
###xml 1504 1508 1504 1508 <italic>oct4</italic>
###xml 1594 1599 1594 1599 <italic>et al</italic>
###xml 1591 1605 1591 1605 <xref ref-type="bibr" rid="b18">Li <italic>et al</italic>, 2007</xref>
###xml 1635 1639 1635 1639 <italic>oct4</italic>
###xml 2108 2111 2108 2111 <italic>cis</italic>
###xml 2262 2267 2262 2267 <italic>et al</italic>
###xml 2258 2273 2258 2273 <xref ref-type="bibr" rid="b13">Kim <italic>et al</italic>, 2009</xref>
###xml 2367 2374 2367 2374 <italic>de novo</italic>
###xml 2450 2457 2450 2457 <italic>de novo</italic>
###xml 105 108 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 283 286 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1912 1915 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 2314 2317 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The results shown here indicate that Np95 interacts with Dnmt3a and Dnmt3b and mediates silencing of the CMV promoter by mechanisms that are, at least initially, independent of de novo DNA methylation. Importantly, our data also show the involvement of H3K9MTs, G9a and Suv39h1/2 in CMV promoter silencing. H3K9MTs were reported to associate with de novo Dnmts, and major satellite repeats were found to be hypomethylated in ESCs lacking either Suv39h1/2 or Dnmt3 enzymes. However, major satellite transcript levels were altered only in Suv39h1/2-deficient cells and not in Dnmt3-deficient cells (Fuks et al, 2003; Lehnertz et al, 2003; Martens et al, 2005). A recent study showed that G9a, Dnmt1, Dnmt3a and Dnmt3b are required for normal methylation at long terminal repeats of endogenous retrotransposable elements, although transcription of these elements was increased in Dnmt-deficient ESCs, but not G9a-deficient ESCs (Dong et al, 2008). Furthermore, recent studies have shown that G9a interacts with Dnmt3a and Dnmt3b and mediates de novo methylation of the oct4, nanog and dnmt3l promoters on retinoic-acid-induced differentiation of ESCs (Feldman et al, 2006; Li et al, 2007; Epsztejn-Litman et al, 2008). However, two of these studies showed that neither G9a nor de novo Dnmts are required to silence the oct4 promoter, and G9a was also found to be dispensable for silencing the nanog and dnmt3l promoters (Feldman et al, 2006; Epsztejn-Litman et al, 2008). In the third study, nanog, but not oct4, was shown to be silenced in differentiating ESCs lacking both Dnmt3a and Dnmt3b (Li et al, 2007). We found that silencing of oct4 during embryoid body differentiation is largely independent from the presence of Np95 as well as all three major Dnmts, and occurs in the absence of DNA methylation (D.M., F.S., S.B., and H.L., unpublished data). These data, together with our findings on silencing of the CMV promoter in ESCs, indicate that Dnmts, Np95 and H3K9MTs mediate silencing through many mechanisms that do not necessarily involve DNA methylation and might depend on the presence of different cis elements and an intricate interplay with other epigenetic and transcription factors. Interestingly, Np95 was recently shown to interact with G9a (Kim et al, 2009) and here we show that silencing of the CMV promoter in ESCs strictly depends on Np95 and on de novo Dnmts as well as G9a. Taken together these observations suggest that Np95, de novo Dnmts and G9a might be involved in a common silencing pathway.
###end p 12
###begin p 13
###xml 96 103 96 103 <italic>de novo</italic>
In summary, our data clearly support a crucial role of Np95 in epigenetic silencing mediated by de novo DNA and histone methyltransferases, and make Np95 an attractive target for epigenetic reprogramming strategies.
###end p 13
###begin title 14
Methods
###end title 14
###begin p 15
###xml 0 30 0 30 <bold>Cell culture and transfection.</bold>
###xml 123 128 123 128 <italic>et al</italic>
###xml 111 134 111 134 <xref ref-type="bibr" rid="b23">Schermelleh <italic>et al</italic> (2007</xref>
###xml 220 225 220 225 <italic>dnmt1</italic>
###xml 225 228 225 228 <sup>&#8722;/&#8722;</sup>
###xml 294 299 294 299 <italic>et al</italic>
###xml 290 305 290 305 <xref ref-type="bibr" rid="b15">Lei <italic>et al</italic>, 1996</xref>
###xml 562 567 562 567 <italic>et al</italic>
###xml 553 573 553 573 <xref ref-type="bibr" rid="b27">Zolghadr <italic>et al</italic> (2008</xref>
Cell culture and transfection. HEK293T cells, BHK cells and ESCs were cultured and transfected as described by Schermelleh et al (2007), except FuGENE HD (Roche, Mannheim, Germany) was used for transfection of ESCs. The dnmt1-/- J1 ESCs used in this study were homozygous for the c allele (Lei et al, 1996). BHK cells were co-transfected on glass coverslips with GFP-Dnmt3 and Cherry-Np95 constructs using Transfectin (Bio-Rad, Munich, Germany) according to the manufacturer's instructions. Cell fixation and microscopy were carried out as described by Zolghadr et al (2008).
###end p 15
###begin p 16
###xml 0 23 0 23 <bold>Co-immunoprecipitation.</bold>
###xml 292 297 292 297 <italic>et al</italic>
###xml 282 303 282 303 <xref ref-type="bibr" rid="b22">Rothbauer <italic>et al</italic>, 2008</xref>
###xml 347 352 347 352 <italic>et al</italic>
###xml 338 358 338 358 <xref ref-type="bibr" rid="b6">Citterio <italic>et al</italic>, 2004</xref>
###xml 1066 1071 1066 1071 <italic>et al</italic>
###xml 1057 1077 1057 1077 <xref ref-type="bibr" rid="b11">Grohmann <italic>et al</italic>, 2005</xref>
###xml 320 326 <span type="species:ncbi:9986">rabbit</span>
###xml 705 710 <span type="species:ncbi:10090">mouse</span>
###xml 1007 1013 <span type="species:ncbi:9986">rabbit</span>
###xml 1080 1091 <span type="species:ncbi:3704">Horseradish</span>
###xml 1114 1120 <span type="species:ncbi:9986">rabbit</span>
###xml 1126 1131 <span type="species:ncbi:10090">mouse</span>
###xml 1135 1139 <span type="species:ncbi:9925">goat</span>
###xml 1145 1151 <span type="species:ncbi:9986">rabbit</span>
Co-immunoprecipitation. ESCs and HEK293T cell extracts were prepared in lysis buffer (20 mM Tris-HCl (pH 7.5), 0.5 mM EDTA, 2 mM phenylmethyl sulphonyl fluoride and 0.5% NP40) containing 150 or 300 mM NaCl (high-salt condition) and diluted with lysis buffer without NP40. GFP trap (Rothbauer et al, 2008) and a specific rabbit antiserum (Citterio et al, 2004) were used for immunoprecipitation of GFP fusions and endogenous Np95, respectively. GFP trap and protein G beads (Sigma, Taufkirchen, Germany) were washed with dilution buffer containing increasing salt concentrations (150 and 300 mM, or 300 and 500 mM NaCl for the high-salt condition) and re-suspended in SDS-PAGE sample buffer. The following mouse monoclonal antibodies were used for immunoblotting: anti-His (C-terminal, Invitrogen, Karlsruhe, Germany), anti-Dnmt3a (clone 64B1446, Imgenex, San Diego, CA, USA) and anti-Dnmt3b (clone 52A1018, Abcam, Cambridge, UK). Np95 was detected with the same antiserum used for immunoprecipitation and a rabbit antiserum was used for detection of Dnmt1 (Grohmann et al, 2005). Horseradish peroxidase-conjugated rabbit anti-mouse or goat anti-rabbit secondary antibodies (Sigma) and ECL Plus reagent (GE Healthcare, Munich, Germany) were used for detection.
###end p 16
###begin p 17
###xml 0 16 0 16 <bold>Silencing assay.</bold>
###xml 767 788 767 788 <xref ref-type="supplementary-material" rid="S1">supplementary Fig S4A</xref>
Silencing assay. ESCs were co-transfected with pCAG-eGFP-IB and pCMV-mRFP as described above and images from live cells were acquired at the indicated time points with an InCell Analyser 1000 (GE Healthcare) using a x 20 air objective (NA=0.45) and standard filter settings for GFP and RFP. A total of 90-150 images were acquired for each channel, using the same exposure time throughout the time course. Cells were passaged every second day and images were taken 4-5 h after seeding. Images were analysed using ImageJ v1.42a software. To calculate fluorescent reporter expression, pictures were processed using a Gaussian blur algorithm (radius (sigma)=2), and a threshold for maximal signal and minimal background coverage was adjusted and applied to each channel (supplementary Fig S4A online). The threshold was converted into area selection and the total size of the selected area was measured.
###end p 17
###begin p 18
###xml 0 25 0 25 <bold>DNA methylation analysis.</bold>
###xml 516 519 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 552 555 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
DNA methylation analysis. ESCs were transfected as in the silencing assay with pCAG-eGFP-IB and pCMV-mRFP, and GFP-positive cells were sequentially sorted with a FACSVantage or FACSAria II (Becton Dickinson, Heidelberg, Germany) at days 2, 6 and 10 after transfection. After each sorting, total DNA was isolated using the QIAmp DNA Mini kit (Qiagen, Hilden, Germany) and bisulphite treated with the EZ DNA Methylation-Gold kit (Zymo research, Orange, CA, USA). The following primers were used for PCR amplification: CMV-forward TGGGATTTTTTTATTTGGTAGT; CMV-reverse ATGGGAGTTTGTTTTGGTATTA; CAG-forward GGAGAGGTGAGGAGGTAGTTAATTAGA and CAG-reverse CCCCAAACCCCTCAAAACTT. Pyrosequencing was carried out by Varionostic GmbH (Ulm, Germany).
###end p 18
###begin p 19
###xml 0 25 0 25 <bold>Supplementary information</bold>
###xml 42 54 42 54 <italic>EMBO reports</italic>
Supplementary information is available at EMBO reports online ().
###end p 19
###begin title 20
Supplementary Material
###end title 20
###begin p 21
Supplementary Information
###end p 21
###begin p 22
###xml 97 101 97 101 <italic>np95</italic>
###xml 101 104 101 104 <sup>&#8722;/&#8722;</sup>
###xml 136 141 136 141 <italic>dnmt1</italic>
###xml 141 144 141 144 <sup>&#8722;/&#8722;</sup>
###xml 201 210 201 210 <italic>Suv39h1/2</italic>
###xml 253 256 253 256 <italic>G9a</italic>
###xml 256 259 256 259 <sup>&#8722;/&#8722;</sup>
###xml 157 163 <span type="species:ncbi:212708">Masaki</span>
We are grateful to the following colleagues for providing ESCs: M. Muto and H. Koseki for wt and np95-/- E14; E. Li and T. Chen for wt, dnmt1-/- and DKO J1; Masaki Okano for TKO J1; Gunnar Schotta for Suv39h1/2 dn; Y. Shinkai and T. Jenuwein for wt and G9a-/- TT2. We thank L. Schermelleh for help with image processing and K. Zolghadr for assistance with the InCell Analyzer. This study was supported by the Nanosystems Initiative Munich and BioImaging Network Munich, and by grants from the Deutsche Forschungsgemeinschaft to H.L.
###end p 22
###begin p 23
The authors declare that they have no conflict of interest.
###end p 23
###begin article-title 24
The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. 
###end article-title 24
###begin article-title 25
Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. 
###end article-title 25
###begin article-title 26
###xml 77 82 <span type="species:ncbi:9606">human</span>
Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. 
###end article-title 26
###begin article-title 27
DNA methylation patterns and epigenetic memory. 
###end article-title 27
###begin article-title 28
UHRF1 plays a role in maintaining DNA methylation in mammalian cells. 
###end article-title 28
###begin article-title 29
Np95 is a histone-binding protein endowed with ubiquitin ligase activity. 
###end article-title 29
###begin article-title 30
DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity. 
###end article-title 30
###begin article-title 31
###xml 0 7 0 7 <italic>De novo</italic>
De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. 
###end article-title 31
###begin article-title 32
G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. 
###end article-title 32
###begin article-title 33
The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. 
###end article-title 33
###begin article-title 34
Restricted mobility of Dnmt1 in preimplantation embryos: implications for epigenetic reprogramming. 
###end article-title 34
###begin article-title 35
The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. 
###end article-title 35
###begin article-title 36
UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. 
###end article-title 36
###begin article-title 37
Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. 
###end article-title 37
###begin article-title 38
###xml 0 7 0 7 <italic>De novo</italic>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. 
###end article-title 38
###begin article-title 39
A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. 
###end article-title 39
###begin article-title 40
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. 
###end article-title 40
###begin article-title 41
Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. 
###end article-title 41
###begin article-title 42
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
The profile of repeat-associated histone lysine methylation states in the mouse epigenome. 
###end article-title 42
###begin article-title 43
###xml 59 66 59 66 <italic>de novo</italic>
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. 
###end article-title 43
###begin article-title 44
Np95 is implicated in pericentromeric heterochromatin replication and in major satellite silencing. 
###end article-title 44
###begin article-title 45
A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. 
###end article-title 45
###begin article-title 46
Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation. 
###end article-title 46
###begin article-title 47
The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. 
###end article-title 47
###begin article-title 48
###xml 111 116 <span type="species:ncbi:9606">human</span>
DNMT1 but not its interaction with the replication machinery is required for maintenance of DNA methylation in human cells. 
###end article-title 48
###begin article-title 49
Temporal and spatial localization of novel nuclear protein NP95 in mitotic and meiotic cells. 
###end article-title 49
###begin article-title 50
A fluorescent two-hybrid (F2H) assay for direct visualization of protein interactions in living cells. 
###end article-title 50
###begin p 51
###xml 20 27 20 27 <italic>de novo</italic>
###xml 67 68 67 68 <bold>A</bold>
###xml 134 138 134 138 <italic>np95</italic>
###xml 138 141 138 141 <sup>&#8722;/&#8722;</sup>
###xml 202 203 202 203 <bold>B</bold>
###xml 256 259 256 259 <italic>lac</italic>
###xml 525 526 524 525 <bold>C</bold>
###xml 1024 1025 1023 1024 <bold>A</bold>
###xml 1032 1033 1031 1032 <bold>C</bold>
###xml 1179 1184 <span type="species:ncbi:9606">human</span>
Np95 interacts with de novo methyltransferases Dnmt3a and Dnmt3b. (A) Co-immunoprecipitation of Dnmt3a and Dnmt3b with Np95 in wt and np95-/- E14 ESCs. The Dnmt3a2 isoform is shown in the lower panel. (B) F2H shows recruitment of Cherry-Np95 (prey) at the lac operator array (indicated by arrowheads) when GFP fusions of full-length Dnmt3a and Dnmt3b1 (G-Dnmt3a/b fl) or their amino-terminal regions (G-Dnmt3a/b N) are used as bait and not with their isolated C-terminal catalytic domains (G-Dnmt3a/b C). Scale bars, 5 mum. (C) Co-immunoprecipitation of Np95-His with GFP-tagged Dnmt1, Dnmt3a and Dnmt3b1 (G-Dnmt) transiently co-expressed in HEK293T cells. Co-expression of GFP was used as the control. In the upper row, immunoprecipitations carried out in the presence of 150 mM NaCl throughout the procedure are shown, whereas in the lower row, immunoprecipitation and wash buffers were carried out using 300 and 500 mM NaCl, respectively. Two per cent of input and supernatant relative to bound fractions were loaded in (A) and (C). B, bound; Dnmt, DNA methyltransferase; ESCs, embryonic stem cells; F2H, fluorescent two-hybrid assay; GFP, green fluorescent protein; HEK293T, human embryonic kidney 293T; I, input; Np95, nuclear protein of 95 kDa; S, supernatant; wt, wild type.
###end p 51
###begin p 52
###xml 263 264 263 264 <bold>A</bold>
###xml 331 332 331 332 <bold>B</bold>
###xml 523 524 523 524 <bold>A</bold>
###xml 593 598 593 598 <italic>suv39</italic>
###xml 598 601 598 601 <sup>&#8722;/&#8722;</sup>
###xml 642 643 642 643 <bold>C</bold>
###xml 677 681 677 681 <italic>np95</italic>
###xml 681 684 681 684 <sup>&#8722;/&#8722;</sup>
###xml 716 717 716 717 <bold>A</bold>
###xml 724 725 724 725 <bold>B</bold>
###xml 130 133 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 822 825 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 841 848 <span type="species:ncbi:9031">chicken</span>
###xml 870 873 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Promoter silencing activity in wild-type and mutant ESCs. ESCs with the indicated phenotypes were transiently co-transfected with CMV promoter-driven mRFP and CAG promoter-driven GFP reporter constructs. Between 90 and 150 images per sample were acquired either (A) every second day after transfection from a single experiment or (B) only at days 2 and 7-10 after transfection from 3-5 independent experiments. Relative levels of red over green fluorescence are shown with values for day 2 (first day of imaging) set to 1 (A). Wild-type J1 and E14 cells gave similar results (data not shown). suv39-/- stands for Suv39h1/2 double null ESCs. (C) Representative images of wt and np95-/- E14 ESCs co-transfected as in (A) and (B) (upper panels) and respective heat map intensity plots (lower panels). Scale bar, 15 mum. CAG, CMV early enhancer/chicken beta actin promoter; CMV, cytomegalovirus promoter; DKO, double knockout; Dnmt, DNA methyltransferase; ESCs, embryonic stem cells; GFP, green fluorescent protein; mRFP, monomeric red fluorescent protein; Np95, nuclear protein of 95 kDa; TKO, triple knockout; wt, wild type.
###end p 52
###begin p 53
###xml 83 87 83 87 <italic>np95</italic>
###xml 87 90 87 90 <sup>&#8722;/&#8722;</sup>
###xml 119 124 119 124 <xref ref-type="fig" rid="f2">Fig 2</xref>
###xml 364 365 364 365 <bold>A</bold>
###xml 504 505 504 505 <bold>B</bold>
###xml 512 513 512 513 <bold>C</bold>
###xml 621 622 621 622 <bold>B</bold>
###xml 623 624 623 624 <bold>C</bold>
###xml 678 679 678 679 <bold>B</bold>
###xml 689 690 689 690 <bold>C</bold>
###xml 692 696 692 696 <italic>np95</italic>
###xml 696 699 696 699 <sup>&#8722;/&#8722;</sup>
###xml 19 22 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 303 306 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 736 739 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Methylation of the CMV promoter 2, 6 and 10 days after transfection. Wild-type and np95-/- ESCs were transfected as in Fig 2 and GFP-positive cells were sequentially sorted at the indicated days after transfection. Total DNA was isolated from sorted cells and bisulphite-treated. A proximal part of the CMV promoter was amplified and subjected to pyrosequencing. (A) Schematic drawing of the 14 proximal CpG sites analysed (shown as open circles). The numbers above correspond to the CpG sites shown in (B) and (C) and numbers in brackets refer to the position of CpG sites with respect to the transcription start site. (B,C) Methylation percentage at individual CpG sites for (B) wt and (C) np95-/- ESCs as measured by pyrosequencing. CMV, cytomegalovirus; ESCs, embryonic stem cells; GFP, green fluorescent protein; wt, wild type.
###end p 53

